Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Abeloff

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
The clinical significance of variant-morphology small-cell carcinoma of the lungS C Aisner, D M Finkelstein, D S Ettinger, et al.
Cancer|July 1, 1983
Serum protein-bound carbohydrates and small cell carcinoma of the lung. Correlations with extent of disease, tumor burden, survival, and clinical response categoriesT P Waalkes, M D Abeloff, D S Ettinger, et al.
Journal of Surgical Oncology|January 1, 1981
Multiple biological markers and breast carcinoma: a preliminary study in the detection of recurrent disease after primary therapyT P Waalkes, M D Abeloff, D S Ettinger, et al.
Cancer Treatment Reports|July 1, 1981
Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lungM D Abeloff, D S Ettinger, S E Order, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1982
Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lungT P Waalkes, M D Abeloff, D S Ettinger, et al.
The New England Journal of Medicine|July 20, 1978
Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implicationsS B Baylin, W R Weisburger, J C Eggleston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1984
Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesisM D Abeloff, M Slavik, G D Luk, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancerS Subramanyan, M D Abeloff, S E Bond, et al.
Cancer|December 1, 1982
Biological markers and small cell carcinoma of the lung: a clinical evaluation of urinary ribonucleosidesT P Waalkes, M D Abeloff, D S Ettinger, et al.
Cancer|March 26, 1999
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinomaB Mikhak, M Zahurak, M D Abeloff, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
The clinical significance of variant-morphology small-cell carcinoma of the lungS C Aisner, D M Finkelstein, D S Ettinger, et al.
Cancer|July 1, 1983
Serum protein-bound carbohydrates and small cell carcinoma of the lung. Correlations with extent of disease, tumor burden, survival, and clinical response categoriesT P Waalkes, M D Abeloff, D S Ettinger, et al.
Journal of Surgical Oncology|January 1, 1981
Multiple biological markers and breast carcinoma: a preliminary study in the detection of recurrent disease after primary therapyT P Waalkes, M D Abeloff, D S Ettinger, et al.
Cancer Treatment Reports|July 1, 1981
Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lungM D Abeloff, D S Ettinger, S E Order, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1982
Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lungT P Waalkes, M D Abeloff, D S Ettinger, et al.
The New England Journal of Medicine|July 20, 1978
Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implicationsS B Baylin, W R Weisburger, J C Eggleston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1984
Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesisM D Abeloff, M Slavik, G D Luk, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancerS Subramanyan, M D Abeloff, S E Bond, et al.
Cancer|December 1, 1982
Biological markers and small cell carcinoma of the lung: a clinical evaluation of urinary ribonucleosidesT P Waalkes, M D Abeloff, D S Ettinger, et al.
Cancer|March 26, 1999
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinomaB Mikhak, M Zahurak, M D Abeloff, et al.
Pageof 9